Streetbeat News

Products Services

RCAT

Red Cat Holdings' new military-grade sUAS, the Teal 2, has received clearance from the U.S. Department of Defense (DoD) to be designated as a Blue UAS. The Blue UAS Cleared List is a select group of DoD-approved drones for government users, ensuring they are NDAA compliant, cyber-secure, and safe to fly.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 12:37 pm

CMMB

Chemomab Therapeutics reported positive secondary Phase 2a liver fibrosis trial results for CM-101 in NASH patients. The data showed improvements in inflammatory and fibrotic biomarkers, with greater biomarker response in high-risk patients. CMMB shares are up 9.2% in premarket trading.

Portfolio Pulse from Vandana Singh

June 21, 2023 | 12:36 pm

BNED

Barnes & Noble College has launched Be Well. Be You.™, a collection of health and wellness solutions for college students. The initiative aims to address students' physical and mental wellbeing by offering easy access to wellness products in campus bookstores and online.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2023 | 12:35 pm

MSFT

Bill Gates, co-founder of Microsoft, expressed optimism about the potential of artificial intelligence (AI) to revolutionize education during an event in Lagos, Nigeria. He emphasized that AI could simplify complex subjects, assist teachers, and create personalized sets of questions for students.

Portfolio Pulse from Benzinga Newsbot

June 21, 2023 | 12:35 pm

LLY

The FDA has approved Jardiance and Synjardy, new oral medicines for children with type 2 diabetes, providing a new class of treatments. The approvals were granted to Boehringer Ingelheim, which has an alliance with Eli Lilly And Co (NYSE:LLY) in diabetes treatment.

Portfolio Pulse from Vandana Singh

June 21, 2023 | 12:32 pm

PFE

Pfizer's vaccine demonstrated 78.6% efficacy in preventing RSV-related disease with 3 or more symptoms in the middle of the second RSV season, and 48.9% efficacy in preventing RSV-related disease with 2 or more symptoms.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 12:32 pm

CRMD

CorMedix announced that the FDA has accepted the resubmission of its New Drug Application (NDA) for DefenCath, a novel system to predict and help prevent adverse food reactions using personal medical data. The patent also describes algorithms to determine safety levels of food ingredients, offering a personalized approach to dietary interventions and safety.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2023 | 12:31 pm

ASTS

AST SpaceMobile announced that it has achieved 4G capabilities to everyday smartphones directly from space, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2023 | 12:31 pm

VTGN

Vistagen announces favorable safety and tolerability data from its U.S. Phase 1 clinical trial of itruvone (PH10), a rapid-onset pherine nasal spray for the treatment of major depressive disorder (MDD). The results enable Phase 2B development of itruvone in the U.S.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 12:31 pm

SPRC

SciSparc has announced IRB approval to conduct its Phase IIB study in Tourette Syndrome, marking a significant milestone for the company.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2023 | 12:30 pm